Low‐dose caffeine administration increases fatty acid utilization and mitochondrial turnover in C2C12 skeletal myotubes

Abstract

Caffeine has been shown to directly increase fatty acid oxidation, in part, by promoting mitochondrial biogenesis. Mitochondrial biogenesis is often coupled with mitophagy, the autophagy-lysosomal degradation of mitochondria. Increased mitochondrial biogenesis and mitophagy promote mitochondrial turnover, which can enhance aerobic metabolism. In addition, recent studies have revealed that cellular lipid droplets can be directly utilized in an autophagy-dependent manner, a process known as lipophagy. Although caffeine has been shown to promote autophagy and mitochondrial biogenesis in skeletal muscles, it remains unclear whether caffeine can increase lipophagy and mitochondrial turnover in skeletal muscle as well. The purpose of this study was to determine the possible contribution of lipophagy to caffeine-dependent lipid utilization. Furthermore, we sought to determine whether caffeine could increase mitochondrial turnover, which may also contribute to elevated fatty acid oxidation. Treating fully differentiated C2C12 skeletal myotubes with 0.5 mM oleic acid (OA) for 24 hr promoted an approximate 2.5fold increase in cellular lipid storage. Treating skeletal myotubes with 0.5 mM OA plus 0.5 mM caffeine for an additional 24 hr effectively returned cellular lipid stores to control levels, and this was associated with an increase in markers of autophagosomes and autophagic flux, as well as elevated autophagosome density in TEM images. The addition of autophagy inhibitors 3-methyladenine (10 mM) or bafilomycin A1 (10 μM) reduced caffeine-dependent lipid utilization by approximately 30%. However, fluorescence and transmission electron microscopy analysis revealed no direct evidence of lipophagy in skeletal myotubes, and there was also no lipophagy-dependent increase in fatty acid oxidation. Finally, caffeine treatment promoted an 80% increase in mitochondrial turnover, which coincided with a 35% increase in mitochondrial fragmentation. Our results suggest that caffeine administration causes an autophagy-dependent decrease in lipid content by increasing mitochondrial turnover in mammalian skeletal myotubes. K E Y W O R D Scaffeine, lipid utilization, mitochondrial turnover, mitophagy, skeletal muscle

Modulation of autophagy by an innovative phytocosmetic preparation (Myrothamnus flabelifolia and Coffea arabica) in human fibroblasts and its effects in a clinical randomized placebo‐controlled trial

“…29,30 Caffeine, the main active component of C. arabica, is reported as a potent activator of autophagy that acts by different mechanisms, increasing LC3 autophagosomal marker expression in neuronal, liver, muscle, and heart cells, inhibiting mTOR complex 1 in the liver, muscle, and heart cells, inducing lipophagy in skeletal myotubes and hepatic cells, and protecting skin from oxidative stress and cell senescence induced by ultraviolet radiation via activation of adenosine monophosphateactivated protein kinase (AMPK)-mediated autophagy in human keratinocytes. 7,[32][33][34]…”

Real‐time and Multichannel Measurement of Contractility of hiPSC‐Derived 3D Skeletal Muscle using Fiber Optics‐Based Sensing

“…We decided to use drugs whose acute effects on force production could be potentially assessed in a short time frame. Caffeine [19][20][21][22][23][24][25][26][27]9] and verapamil [28,29,9] have opposite effects on calcium dynamics in muscle fibers. Caffeine is an agonist of the ryanodine receptor (RyR) on the SR, inducing a greater calcium flux towards the cytosol and therefore ultimately promoting higher contraction forces.…”

Mitophagy and mitochondrial dynamics in type 2 diabetes mellitus treatment

“…It has been demonstrated to reduce the autophagy-dependent lipid concentration in hepatic tissues through lipophagy [ 89 ]. Besides, caffeine also demonstrated that to activate mitophagy for increasing fatty acid oxidation as well as mitochondrial biogenesis as accompanied with potentiated the rate of mitochondrial degradation in skeletal muscle [ 77 ].…”